Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …

Background Central lymph node metastasis (CLNM) is common in papillary thyroid
carcinoma (PTC). Prophylactic central lymph node dissection (PCLND) for patients with …

Introduction Papillary thyroid carcinoma (PTC) generally shows an excellent prognosis
except in cases with aggressive backgrounds or clinicopathological features. Although the …

Background The prevalence of thyroid carcinoma (TC) and Hashimoto's thyroiditis (HT) has
been increasing dramatically over the past decades. We investigated the relationship …

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Objectives To screen out the predictors of central cervical lymph node metastasis (CLNM) for
papillary thyroid carcinoma (PTC) and establish a prediction model to guide the operation of …

Background Incidence rates of thyroid cancer (TC) increased in several countries during the
last 30 years, while mortality rates remained unchanged, raising important questions for …

Papillary thyroid carcinoma (PTC) is the fastest-growing disease caused by numerous
molecular alterations in addition to previously reported DNA mutations. There is a …

Purpose Preoperative neck ultrasound (US) for lateral cervical lymph nodes is
recommended for all patients undergoing thyroidectomy for thyroid malignancy, but it is …

Simple Summary Differentiated thyroid cancer (DTC) is the most common endocrine
malignancy with a high incidence rate in females. The COVID-19 epidemic posed an …